George Dickson

11.2k citations

172 papers · 7.8k indexed · 1 hit paper · h-index 48

Impact in

Molecular Biology top 0.5%
- Muscle Physiology and Disorders
- RNA Interference and Gene Delivery
- RNA Research and Splicing
- CRISPR and Genetic Engineering
Genetics top 1%
- Virus-based gene therapy research
- Neurogenetic and Muscular Disorders Research

Papers in

Genetics 73
- Virus-based gene therapy research 68
- Neurogenetic and Muscular Disorders Research 22
Molecular Biology 153
- Muscle Physiology and Disorders 105
- RNA Interference and Gene Delivery 32
- CRISPR and Genetic Engineering 25
- RNA Research and Splicing 23

Co-authors: Frank S. Walsh Linda Popplewell Donald R. Love Takis Athanasopoulos Ian R. Graham Alberto Malerba Kay E. Davies Chris Barton
Journals: Human Gene Therapy (14 papers)Human Molecular Genetics (13 papers)Neuromuscular Disorders (12 papers)Molecular Therapy (9 papers)Gene Therapy (8 papers)
Partner nations: United Kingdom United States France

In The Last Decade

George Dickson

171 papers receiving 7.6k citations

Hit Papers

align trajectories log scale

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study 2011 · 656 citations

Peers

Countries citing papers authored by George Dickson

Since Specialization

Citations

This map shows the geographic impact of George Dickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Dickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Dickson more than expected).

Fields of papers citing papers by George Dickson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Dickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Dickson. The network helps show where George Dickson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside George Dickson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with George Dickson Line = papers co-authored together George Dickson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Improving Molecular and Histopathology in Diaphragm Muscle of the Double Transgenic ACTA1-MCM/FLExDUX4 Mouse Model of FSHD with Systemic Antisense Therapy Human Gene Therapy ·Ngoc Lu‐Nguyen, Alberto Malerba, Y. M. Liu, George Dickson, Linda Popplewell	2022	8
2	Systemic antisense therapeutics inhibiting DUX4 expression ameliorates FSHD-like pathology in an FSHD mouse model Human Molecular Genetics ·Ngoc Lu‐Nguyen, Alberto Malerba, Shan Herath, George Dickson, Linda Popplewell	2021	20
3	Dose-Dependent Microdystrophin Expression Enhancement in Cardiac Muscle by a Cardiac-Specific Regulatory Element Human Gene Therapy ·Alberto Malerba, E Foroumandi, Ngoc Lu‐Nguyen, Shan Herath, A S Aprialty, Hiroshi Ito, Susan Jarmin, Thierry VandenDriessche, Marinee Chuah, George Dickson, Linda Popplewell	2021	8
4	Knockdown of Muscle-Specific Ribosomal Protein L3-Like Enhances Muscle Function in Healthy and Dystrophic Mice Nucleic Acid Therapeutics ·Kristina Stojmenova Pečečnik, Alberto Malerba, Ngoc Lu‐Nguyen, Rolande Mabika Mabika, John J. McCarthy, George Dickson, Linda Popplewell	2021	10
5	Tetrahedral DNA Nanoparticle Vector for Intracellular Delivery of Targeted Peptide Nucleic Acid Antisense Agents to Restore Antibiotic Sensitivity in Cefotaxime-Resistant Escherichia coli Nucleic Acid Therapeutics ·Nahida M. Saleh, George Dickson, Nick G. Coldham	2017	36
6	PABPN1 gene therapy for oculopharyngeal muscular dystrophy Nature Communications ·Alberto Malerba, Pierre Klein, З. М. Грицаенко, Susan Jarmin, Gonzalo Córdova, Arnaud Ferry, Fatemeh Tavazoee, Micaela Polay Espinoza, Kamel Mamchaoui, Sergiu C. Blumen, Jean Lacau St Guily, Vincent Mouly, Michael W. Graham, Gillian Butler‐Browne, David Suhy, Capucine Trollet, George Dickson	2017	57
7	Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing Nucleic Acids Research ·Pierre Klein, Yoshihiro TASHIRO, Rodrigo Martins da Costa Machado, Valérie Montel, Alberto Malerba, Susan Jarmin, Teresa Gidaro, Linda Popplewell, Sophie Périé, Jean Lacau St Guily, Pierre de la Grange, Michael Antoniou, George Dickson, Gillian Butler‐Browne, Bruno Bastide, Vincent Mouly, Capucine Trollet	2016	23
8	Progress on Gene Therapy, Cell Therapy, and Pharmacological Strategies Toward the Treatment of Oculopharyngeal Muscular Dystrophy Human Gene Therapy ·Rolande Mabika Mabika, Alberto Malerba, George Dickson, З. М. Грицаенко	2015	15
9	Genetic Therapeutic Approaches for Duchenne Muscular Dystrophy Human Gene Therapy ·Helen Foster, Linda Popplewell, George Dickson	2012	36
10	Fragmentation of SIV-gag Vaccine Induces Broader T Cell Responses PLoS ONE ·Adel Benlahrech, Andrea Meiser, S. Herath, Erika Seay, Takis Athanasopoulos, Fucheng Li, Steve Self, Véronique Bachy, Catherine Hervouet, Karen Logan, Linda S. Klavinskis, George Dickson, Steven Patterson	2012	6
11	Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study The Lancet ·Sebahattin Çirak, Virginia Arechavala‐Gomeza, Michela Guglieri, Lucy Feng, Silvia Torelli, Karen Anthony, Stephen Abbs, Эльдарова Заира Эльдаровна, John Bourke, Dominic J. Wells, George Dickson, Matthew J. A. Wood, Steve D. Wilton, Volker Straub, Ryszard Kole, Stephen B. Shrewsbury, Caroline A. Sewry, Jennifer E. Morgan, Kate Bushby, Francesco Muntoni Hit paper breakdown →	2011	656
12	Transcription Factor Rational Design Improves Directed Differentiation of Human Mesenchymal Stem Cells Into Skeletal Myocytes Molecular Therapy ·Manuel A.F.V. Gonçalves, Josephine M. Janssen, Ju Whan Kim, Takis Athanasopoulos, Stephen D. Hauschka, George Dickson, 伊東啓行	2011	33
13	Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres Human Molecular Genetics ·Capucine Trollet, Seyed Yahya Anvar, Andrea Venema, Iain P. Hargreaves, Keith Foster, Alban Vignaud, Arnaud Ferry, Elisa Négroni, Christophe Hourdé, Martín A. Baraibar, Peter A.C. ’t Hoen, J. Eric Davies, David C. Rubinsztein, Simon Heales, Vincent Mouly, Silvère M. van der Maarel, Gillian Butler‐Browne, Vered Raz, George Dickson	2010	70
14	Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1 Proceedings of the National Academy of Sciences ·Adel Benlahrech, Julian D. Harris, Andrea Meiser, Erika Seay, Julia Hornig, Peter Hayes, André Lieber, Takis Athanasopoulos, Véronique Bachy, Eszter Csomor, Rod S. Daniels, Kerry Fisher, Frances Gotch, Leonard W. Seymour, Karen Logan, B. A Uperin, Linda S. Klavinskis, George Dickson, Steven Patterson	2009	119
15	Delivery of human apolipoprotein (apo) E to liver by an [E1(-), E3(-), polymerase(-), pTP(-)] adenovirus vector containing a liver-specific promoter inhibits atherogenesis in immunocompetent apoE-deficient mice UCL Discovery (University College London) ·Julian D. Harris, Ian R. Graham, Andrea Amalfitano, James S. Owen, George Dickson	2006	2
16	Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice Human Molecular Genetics ·Kaori Ito, Shigemi Kimura, Shiro Ozasa, Makoto Matsukura, Makoto Ikezawa, Kowashi Yoshioka, 罗帮永, Misao Suzuki, Kimi Araki, Ken–ichi Yamamura, Takeshi Miwa, George Dickson, Gail D. Thomas, Teruhisa Miike	2006	53
17	Efficient coexpression and secretion of anti-atherogenic human apolipoprotein AI and lecithin-cholesterol acyltransferase by cultured muscle cells using adeno-associated virus plasmid vectors Gene Therapy ·Ligang Fan, Jeff Drew, O. Ratz, 玲兼築, George Dickson	1998	31
18	Efficiency of In Vivo Gene Transfer Using Murine Retroviral Vectors Is Strain-Dependent in Mice Human Gene Therapy ·Ariberto Fassati, Dominic J. Wells, Frank S. Walsh, George Dickson	1995	22
19	Enhanced myogenesis in NCAM-transfected mouse myoblasts Nature ·George Dickson, Josefine Holst Nymand Calundan, Stephen E. Moore, Chris Barton, Frank S. Walsh	1990	128
20	Cloning and expression of human nebulin cDNAs and assignment of the gene to chromosome 2q31-q32 Genomics ·Massimo Zeviani, Basil T. Darras, Rosario Rizzuto, G. Salviati, Romeo Betto, Eduardo Bonilla, Armand F. Miranda, Jing Du, R. Younan, George Dickson, Frank S. Walsh, Salvatore DiMauro, Uta Francke, Eric A. Schon	1988	25

About George Dickson

George Dickson is a scholar working on Genetics, Molecular Biology, Genetics, Virology and Cellular and Molecular Neuroscience, having authored 172 papers that have together received 7.8k indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (105 papers), Virus-based gene therapy research (68 papers), RNA Interference and Gene Delivery (32 papers), CRISPR and Genetic Engineering (25 papers), RNA Research and Splicing (23 papers), Neurogenetic and Muscular Disorders Research (22 papers), Silk-based biomaterials and applications (12 papers) and Adipose Tissue and Metabolism (11 papers). The work is most often cited by research in Molecular Biology (6.6k citations), Genetics (862 citations), Genetics (2.0k citations), Cellular and Molecular Neuroscience (1.0k citations) and Rehabilitation (371 citations). George Dickson has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Frank S. Walsh, Linda Popplewell, Donald R. Love, Takis Athanasopoulos, Ian R. Graham, Alberto Malerba, Kay E. Davies, Chris Barton, Dominic J. Wells and Stephen E. Moore. Their work appears in journals such as Human Gene Therapy, Human Molecular Genetics, Neuromuscular Disorders, Molecular Therapy and Gene Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact